T * 2 multislice multiecho cardiac magnetic resonance (CMR) allows quantification of the segmental distribution of myocardial iron overload (MIO). We evaluated whether a preferential pattern MIO was preserved between two CMR scans in regularly chelated thalassaemia major (TM) patients.
Introduction
Thalassaemia major (TM) is an inherited disorder of haemoglobin synthesis that results in chronic haemolytic anaemia.
1 Regular blood transfusions are mandatory for long-term survival, but they can cause a secondary state of tissue iron overload since humans have no physiological mechanism for active elimination of excess iron. The iron-induced cardiomyopathy is treatable and reversible if intensive chelation treatment, aimed to remove the iron excess, is instituted in time. 2 Three chelators with differentiated mechanism of action and tissue sensitivity are currently available worldwide: deferoxamine (DFO), deferiprone (DFP), and deferasirox (DFX).
To improve compliance, minimize/reduce toxicity, and enhance iron removal if an additive or synergistic effect occurs, two chelators can be used either sequentially (on different days) or in combination (both given on the same day). 3 However, drug toxicity from overdosing of chelation therapy has to be avoided. Therefore, the direct monitoring of cardiac iron overload is the nodal point in the management of TM patients. To date, cardiac magnetic resonance (CMR) is the only technique that quantitatively and non-invasively assesses cardiac iron burden. 4, 5 Cardiac iron is indicated by a decrease in relaxation time values, determined by the paramagnetic proprieties of iron compounds. 6 The most relevant relaxation parameter is the T * 2 , and two validated approaches generally used in the clinical arena are the single-slice 7 and the multislice approach. 8 In the single-slice approach, the T * 2 value evaluated in a single region of interest drawn in the mid-ventricular septum is taken as representative of the T * 2 value for the whole heart. 9 The multislice approach allows a global analysis of the left ventricle (LV) 8 and consequently the identification of a heterogeneous iron distribution, demonstrated in primis by histological studies performed on haemochromatotic hearts. 10 Importantly, it was shown that the heterogeneity of T * 2 values represented true heterogeneous iron density and could not have been generated by geometric and susceptibility artefacts 11 or by myocardial fibrosis and blood oxygenation. 12 So, the multislice, multiecho T * 2 CMR is ideally suited to non-invasively detect preferential patterns of myocardial iron deposits. A preferential pattern of iron store in the anterior and inferior regions was previously detected in TM patients with severe and mild-moderate iron overload. 13 The prospective evolution of the iron store distribution has never been investigated in patients under chelation therapy. The multislice multiecho T * 2 approach showed a good reproducibility, 8 making it valuable for serial monitoring over time.
This study aimed to determine whether a preferential pattern of myocardial iron overload (MIO) was preserved between two CMR scans in regularly chelated TM patients.
Methods

Study population
The Myocardial Iron Overload in Thalassaemia (MIOT) network was built in Italy in 2006 and has gradually grown, reaching the size of 69 thalassaemia centres and 8 CMR centres where exams are performed using homogeneous, standardized, and validated procedures.
14 An online database was developed to allow the centres to collect and share patients' data. 15 The database contains clinical and instrumental data as well as information about the chelation regimen followed by the patient from the beginning to the date of the last T * 2 CMR. Of the 1380 TM patients enrolled, 812 had a CMR follow-up (FU) study performed at 18 + 3 months, according to the protocol.
All patients had been regularly transfused since early childhood and started chelation therapy from the mid-to-late 1970s, while patients born after the 1970s have received chelation therapy since early childhood. All records were reviewed to assess for changes in chelation regimen based on the results of the baseline CMR. Based on the correspondence between the time history of drug administration and the prescribed regimen, the compliance was defined excellent (.80%), good (60 -80%), and insufficient (,60%). Each CMR scanning was performed within 1 week before the regularly scheduled blood transfusion.
The study complied with the Declaration of Helsinki. All patients gave written informed consent to the protocol. The institutional review board approved this study.
Cardiac magnetic resonance
CMR exams were performed on 1.5-T scanners (GE Signa/Excite HD, Milwaukee, WI, USA) using an eight-element cardiac phased-array receiver surface coil for signal reception.
Three parallel short-axis views (basal, medium, and apical) of the LV were obtained by a T * 2 gradient-echo multiecho sequence with electrocardiogram triggering. Each single short-axis view was acquired at nine echo times (TEs, 2.0 -22 ms with an echo spacing of 2.26 ms) in a single end-expiratory breath-hold. 16 Acquired images were analysed by expert CMR operators in each of eight CMR centres using a previously validated, custom-written software (Hippo-MIOT w ). 16 The software is able to map myocardial T * 2 distribution in a 16-segment LV model according to the American Heart Association standardized segmentation. 17 Six equiangular segments were used in the basal and medium slices and four in the apical slice ( Figure 1A) . For each segment, the mean value of the signal intensity along all the TE values was calculated, and the assessed decay curve was fit to the single exponential model. In heavily iron-overloaded hearts, a truncation model was applied to delete the late points with a low signal-to-noise ratio. 18 An appropriate correction map built using the data of healthy volunteers scanned in the CoreLab of the MIOT Network was implemented within the software to correct for susceptibility artefacts.
16
The inter-site, inter-study, intra-observer, and inter-observer variabilities of the proposed methodology had been previously assessed. 8, 14 The global T * 2 value averaged over all 16 segmental T * 2 values and the T * 2 value in the mid-ventricular septum evaluated by averaging the T * 2 values in segments 8 and 9 were automatically provided. Four different main circumferential regions, such as anterior, septal, inferior, and lateral, were defined by averaging the correspondent T * 2 values ( Figure 1B) . Cardiac iron concentration (CIC) was derived from T * 2 values using the formula described by Carpenter et al. 4 The lower limit of normal was taken as 26 ms for global heart and 24.4 ms for mid-ventricular septum T * 2 value.
14 MIO was considered severe when T * 2 value was ,10 ms. 19 
Statistical analysis
All data were analysed using SPSS v.13.0 (Chicago, IL, USA) statistical package. All continuous variables are expressed as the mean and standard deviation. Correlation analysis was performed using Spearman's test. Comparisons between groups were made by an independent sample t-test or the Mann-Whitney test. A x 2 test was performed for non-continuous variables.
Reproducibility of the T * 2 technique was evaluated using the coefficient of variation (CoV) and the intra-class correlation coefficient (ICC).
Within-group comparisons between baseline and FU T * 2 data were performed by the paired t-test.
The analysis of variance (ANOVA) or the Kruskall-Wallis test in case of no-normal distribution was used to detect the presence of a significant difference among regional T * 2 changes. One-way repeated-measures ANOVA was used to evaluate whether there was a significant difference between different T were females, and mean age was 29.5 + 7.8 years. Baseline clinical data of the analysed patients are summarized in Table 1 . The selected patient population was divided into two groups: severe (n ¼ 80, baseline global T * 2 ,10 ms) and mild -moderate MIO (n ¼ 179, baseline global T * 2 between 10 and 26 ms). The two groups were not different regarding age (severe MIO 29.1 + 6.7 years vs. mildmoderate MIO 29.6 + 8.2 years; P ¼ 0.613) and sex (severe MIO M/F 39/41 vs. mild-moderate MIO 71/108; P ¼ 0.172). Table 2 reports the chelation treatment performed at both CMRs. With only one exception, all patients were under chelation treatment at both the scans. The exception was a patient who at the first CMR had temporarily interrupted the DFO therapy due to a cataract. The percentage of patients who maintained the same therapy between the two scans was significantly different among the regimens [none: 0/1 (0%), DFO: 30/97 (30.9%), DFP: 12/19 (63.2%), DFX: 49/65 (75.4%), sequential DFO/DFP: 12/17 (70.6%), combination DFO + DFP: 39/58 (67.2%), sequential DFP/DFX: 1/1 (100%), and combination DFO + DFX: 0/1 (0%); P , 0.0001]. Although the therapy was the same, 30 patients (21%) changed dosages/frequency after the baseline CMR scan. Among the 116 (45%) patients who changed chelation therapy according to the baseline CMR exam, 61 (52.6%) switched to a dual therapy (i.e. sequential or combined). Globally, based on the CMR reports, 56.4% of patients changed the chelation regimen (dosages/ frequency or drug). Of the 80 patients with severe MIO at baseline, 56 patients (70%) changed the chelation regimen.
The percentage of patients with excellent/good levels of compliance to the active chelation treatment was 87.7% at the baseline and 93.7% at the FU (P ¼ 0.030). Improvement of heart iron by CMR-guided chelation therapy T *
changes
The mean intra-observer variability assessed by CoV from one welltrained operator in each of eight sites was 7.37 + 4.42%. There was high correlation between the T * 2 values calculated from images obtained in Pisa and at the other seven MRI sites concerning the global heart (R ¼ 0.95). The CoV and ICC for the global heart considering all the T * 2 values independently from the sites were, respectively, 8% and 0.97. Table 3 summarizes the global heart and the regional T * 2 and CIC values at both baseline and FU CMRs for the whole selected patient population. A significant increase was detected for all T * 2 values (P , 0.0001 for all the pairwise comparisons). Accordingly, there was a significant reduction in all the regional CIC values (P , 0.0001 for all the pairwise comparisons).The T * 2 improvement was not different among the four regions (P ¼ 0.398).
A significant correlation between the global T * 2 value and the T * 2 value in the mid-ventricular septum was present at both basal and FU CMRs (r ¼ 0.955 and 0.962, respectively, P , 0.0001). At the baseline, 29 (11.2%) of the 259 patients with significant global heart iron overload had a normal mid-ventricular septum T * 2 value. For these patients, the mean global heart T * 2 was 24.18 + 1.79 ms, and the mean mid-ventricular septum T * 2 was 28.15 + 2.87 ms (P , 0.0001). Of the 29 patients with significant global heart iron overload and a normal mid-septum T * 2 value, the 37.9% changed the chelation regimen, and while three patients had an insufficient compliance at the baseline, at the FU only one had an insufficient compliance.
At the FU, 182 of 259 patients (70%) had still a pathological global heart T * 2 value and out of them, 12 (7%) had a normal mid-ventricular septum T * 2 value. For each group, cardiac segments were sorted by a mean T * 2 value (Table 4) . At the baseline as well as at the FU in both groups, the lowest T * 2 value was detected in the medium anterior segment and the highest in the basal inferoseptal segment. For each group, the segment order was significantly preserved between the two scans (severe MIO: r ¼ 1.00, P , 0.0001 and mild-moderate MIO: r ¼ 0.935, P , 0.0001).
For each group, there was a significant improvement in the global heart as well as in regional T * 2 values (P , 0.0001 for all the pairwise comparisons; Table 3 ). Accordingly, for each group, there was a significant reduction in all the regional CIC values (P , 0.0001 for all the pairwise comparisons). Of the patients with mild -moderate iron at baseline, 73 (41%) had a normal global heart T * 2 at the FU. The T * 2 improvement was not statistically different among the regions in either the severe MIO or mild -moderate MIO group (P ¼ 0.263 and 0.719, respectively). The decrease in CIC was significantly higher in the group with severe MIO than in the group with mild -moderate MIO (P , 0.0001 for all the regions).
Patterns of MIO
At the baseline, as well as the FU CMR, a significant circumferential variability was detected in the whole patient population (P , 0.0001 for both CMRs) and the pattern was the same. Specifically, the mean T * 2 value over the anterior region was significantly lower than the mean T * 2 values over the other regions, and the mean T * 2 over the inferior region was significantly lower than the T * 2 values over the septal and the lateral regions. A significant circumferential variability was also preserved within each single slice at both the CMRs (P , 0.0001). A significant slice-to-slice variability was found at both the CMRs (P , 0.0001). A T * 2 value was significantly lower in the medium and in the apical slices than in the basal slice.
A significant circumferential variability was present at the baseline and at the FU CMR in both groups (P , 0.0001; Figures 2A and 3A) . At baseline, the mean T * 2 value over the anterior region was significantly lower than the mean T * 2 values over the other regions, and the mean T * 2 over the inferior region was significantly lower than the T * 2 values over the septal and the lateral regions. Exactly the same pattern was present at the FU for the group with severe MIO. The group with mild -moderate MIO showed a little difference: the mean T * 2 value over the inferior region was lower than that one over the lateral region, but statistical significance was not reached. In each single slice, the significant circumferential variability was preserved in A. Meloni et al.
both groups at both the scans (P , 0.0001 for all the comparisons; Figures 2B and 3B) . A significant slice-to-slice variability was present. For patients with severe MIO, the T * 2 value was significantly lower in the medium and apical slices than in the basal slice at both the scans (P , 0.0001; Figure 2C ). For patients with mild-moderate MIO at baseline, only the T * 2 value in the medium slice was significantly lower than that in the basal slice (P ¼ 0.019), while at the FU, both the mean and the apical slices presented a significantly lower T * 2 value than the basal slice (P ¼ 0.001; Figure 3C ).
Discussion
The introduction of the multislice multiecho T * 2 CMR has made it possible to extend myocardial iron evaluation from the midventricular septum to the entire LV by a segmental approach. 8, 20 This approach has been demonstrated to have a good intra-observer, inter-observer, and inter-study reproducibility, 20 and it has been shown to be transferable among the first six MRI sites enrolled in the MIOT network. 14 Also the intra-and inter-observer variability tested in the eight MRI centres that enrolled patients in this study were demonstrated to be good and concordant with the previously published data. Since possible bias due to susceptibility artefacts can be corrected by applying one standardized T * 2 map of normal human hearts 16 and since anyway the artefacts are additive in the R 2 * (1/T * 2 ) domain and vanish with the progression of iron overload, 21 the multislice approach can account for the heterogeneous myocardial iron distribution. Positano et al. at their first CMR. 13 On the basis of these findings, the aim of this study was to determine whether a preferential pattern of MIO was preserved between two CMR scans in TM patients regularly transfused and chelated. According to our protocol, the FU CMR was performed after 18 + 3 months from the baseline CMR. This timing was a compromise between the monitoring guidelines according to the basal cardiac iron status 5 and the real availability of CMR scans in Italy. 15 Our study prospectively demonstrated a significant increment of global and regional T * 2 values at the FU. Based on the CMR using a segmental approach report, 56.4% of the patients changed chelation regimen (drug or frequency or dosage). Moreover, the discrepancy between global and mid-septum T * 2 values present in one-tenth of the patients strengthens the added value of the multislice approach. In fact, 37.9% of the patients with a normal mid-septum T * 2 value, but a pathological global heart T * 2 value and heterogeneous MIO have changed the chelation regimen, and while three patients had an insufficient compliance at the baseline, at the FU only one had an insufficient compliance.
At the FU, we registered a significantly higher level of compliance to the chelation therapy, probably thanks to the opportunity for the patients to 'touch' directly the iron status of their hearts. Thus, the significant reduction in the cardiac iron burden was likely due to a baseline CMR-guided chelation therapy and to the improvement of the compliance to the chelation therapy.
As cardiac complications in well-chelated, well-monitored TM patients are significantly rarer than previously reported, 23 the pattern of MIO can emerge as the sensitive predictor of cardiac complications in well-chelated TM populations to detect iron overload early and to identify borderline patients, who could particularly take advantage of tailoring chelation therapy for preventing ironrelated heart damage. DFP has been proved to be superior to DFO at removing cardiac iron, 24, 25 and clinical data support the dose-dependent efficacy of DFX in removing and preventing myocardial iron accumulation. 26, 27 This explains while the percentage of patients who remained on DFO was lower than that of patients who continued the two oral monotherapies between scans. It should be pointed out that several patients refused to change the DFO therapy. To our knowledge, low cardiac T * 2 assessed at the first CMR triggered intensification of chelation regimens in 20% of patients. The association between DFP and DFO has been shown to be the most effective means of reducing cardiac iron loading, 28 -30 and, in fact, after the first CMR 61 patients switched to a combined therapy. In the whole selected patient population as well as in both groups, the anterior region showed the lowest improvement, although a significant difference in the T * 2 increase among the four regions was not detected. Converting the T * 2 values to CIC, the decrease in heart iron burden was significantly higher in the group with severe MIO than in the group with mild -moderate MIO (P , 0.0001 for all the regions). Due to the inverse exponential relationship between T * 2 and heart iron, a small improvement in T * 2 values in severely iron-loaded hearts corresponds to a significant clearance of cardiac iron. The finding indirectly reflects also the higher percentage of changes in the chelation regimen based on the CMR reports among the patients with more severe iron deposition.
In this study, we reconfirmed at the baseline the same pattern of MIO detected in a previous study. 13 Most importantly, we found out that the circumferential variability was preserved at the FU, despite the T * 2 increase. To be more precise, for the group with mildmoderate MIO at the FU, the difference between the inferior region and the lateral region lost the statistical significance. It should be pointed out that many patients with mild-moderate MIO at baseline had at the FU normal global and segmental T * 2 values. This finding strongly supports the independence of the patterns from artifactual sources.
Moreover, at both the scans, the circumferential pattern was highly conserved across slices. In a histological study performed on one freshly deceased, unfixed, iron-loaded heart, Ghugre et al. 31 also Improvement of heart iron by CMR-guided chelation therapy reported a slice-to-slice reproducibility. This conservation of the relative relationship among regional T * 2 values also within each single slice seems to indicate the absence of a variable regional response to chelation treatment.
Carpenter et al. 4 reported no systematic variation in mean iron concentration between different LV segments or from base to apex in their T * 2 CMR study against human hearts. Among the patients with severe MIO, the significantly higher myocardial iron burden in their 10 vs. our 80 patients (5.26 + 0.87 vs. 7.29 + 1.74, P ¼ 0.0005) may explain the differences found in our study and in Ghugre's data. 31 We found a significantly lower iron content in the basal slice vs. the medium and apical slices at both basal and FU CMRS. 
Limitations
It was not possible to compare CMR findings with other imaging techniques (i.e. echocardiography), because they were performed with different time intervals in several patients.
Due to the lower rate of cardiac complications in the last years in the thalassaemia population, 23 prospective studies with a significant longer follow-up times are recommended to focalize about the clinical relevance of the T * 2 segmental approach in management of the chelation therapy.
Conclusions
A preferential pattern of iron store in anterior and inferior regions was present at both basal and FU CMRs, with an increment of T * 2 values at FU due to both a baseline CMR-guided chelation regimen and the improvement of the compliance to the chelation therapy. The anterior region seems to be the region in which the iron accumulates first and is removed later. Our data seem to suggest that the segmental T * 2 cardiac MR approach could be useful for identifying early iron deposit and for tailoring chelation therapy in each patient to better prevent cardiac complications.
